Perhaps, this is not surprising since PEG30-FGF21 Q108 at this dose (0.25 mg/kg) was recently reported to have beneficial effects in terms of normalizing insulin-stimulated glucose uptake in a diet-induced mouse model of insulin-resistance after acute treatment [21]. The gene discussed is FGF21; the disease is Insulin resistance.